APA

Sagar D., Singh N. P., Ginwala R., Huang X., Philip R., Nagarkatti M., Nagarkatti P., Neumann K., Ruland J., Andrews A. M., Ramirez S. H., Khan Z. K. & Jain P. (20181218). Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity. : Scientific reports.

Chicago

Sagar Divya, Singh Narendra P, Ginwala Rashida, Huang Xiaofang, Philip Ramila, Nagarkatti Mitzi, Nagarkatti Prakash, Neumann Konstantin, Ruland Jürgen, Andrews Allison M, Ramirez Servio H, Khan Zafar K and Jain Pooja. 20181218. Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity. : Scientific reports.

Harvard

Sagar D., Singh N. P., Ginwala R., Huang X., Philip R., Nagarkatti M., Nagarkatti P., Neumann K., Ruland J., Andrews A. M., Ramirez S. H., Khan Z. K. and Jain P. (20181218). Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity. : Scientific reports.

MLA

Sagar Divya, Singh Narendra P, Ginwala Rashida, Huang Xiaofang, Philip Ramila, Nagarkatti Mitzi, Nagarkatti Prakash, Neumann Konstantin, Ruland Jürgen, Andrews Allison M, Ramirez Servio H, Khan Zafar K and Jain Pooja. Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity. : Scientific reports. 20181218.